Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, named Roundhill Memory ETF (NASDAQ:DRAM) as her final trade.

Jim Lebenthal, partner and chief market strategist at Cerity Partners, picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) after the company agreed to acquire Crinetics Pharmaceuticals (NASDAQ:CRNX).

On Monday, Crinetics and Vertex entered into a definitive agreement under which Vertex will acquire Crinetics for $85 per share in cash, representing a total equity value of approximately $10 billion.

Don’t forget to check out our premarket coverage here

Liz Young Thomas, SoFi’s head of investment strategy, recommended Vanguard Real Estate Index Fund ETF Shares (NYSE:VNQ).

Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked NVIDIA Corporation (NASDAQ:NVDA).

Nvidia shares gained Wednesday following reports suggesting China will let the top AI firms buy a limited amount of Nvidia H200 chips.

Chinese officials recently told Alibaba Group Holding Limited (NYSE:BABA), ByteDance and DeepSeek that they may soon receive permission to purchase some Nvidia H200 chips, the Information reported on Wednesday, citing people familiar with the matter.

Price Action

• Vertex shares fell 4.6% to close at $498.43 on Wednesday.
• Roundhill Memory ETF rose 2.4% during the session.
• Nvidia shares gained 3.7% to close at $204.12 on Wednesday.
• Vanguard Real Estate Index Fund ETF Shares fell 1.6% during the session.

Photo via Shutterstock